Sanderling Ventures
Venture capitalSan Mateo · Seed–Late Stage · 8 people tracked
Also known as SANDERLING MANAGEMENT COMPANY, LLC
Find your way into Sanderling Ventures
8 people in our graph share verified history with the Sanderling Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Sanderling invests in and helps build biomedical companies, combining a specialized investment focus with active management and a long-term commitment. The firm emphasizes close working partnerships with entrepreneurs to build significant companies and generate strong returns for both founders and investors. Areas of specialization include small molecule therapeutics, biologics and vaccines, drug delivery, platform technologies, and medical devices.
Source: firm website, verified Sep 15, 2026.
Team · 8 people
from the firm's website
What they invest in
from 40 of 72 portfolio companiesHealthtech ×28Biotech ×26Medical Devices ×20Digital Health ×3Hardware ×3Deep Tech ×2Advanced Manufacturing ×1AI & Machine Learning ×1
HQs:United States×24Belgium×1Germany×1France×1Netherlands×1
Who they back
founder profiles across 8 portfolio companiesFounding team size:solo founder×52 founders×3
backed the same founder in 2+ companies: 2 founders
Investments · 72 tracked
founders shown can be your intro pathBy year:2023 · 12020 · 22019 · 22017 · 22016 · 22015 · 12012 · 212 dated
HCW Biologics is a clinical-stage biopharmaceutical company developing fusion immunotherapeutics as first-in-class immunotherapies for autoimmune diseases, cancer, and senescence-associated dysplasia.
BiotechHealthtechLongevityMiramar, US
Hing C. Wong(Executive Officer, Director)Hing W.(Founder)inLee Flowers(Executive Officer)Rebecca Byam(Executive Officer)inPeter Rhode(Executive Officer)inPeter Sun(Director)
Board seatFred Middleton· per SEC Form D · $16M raise · filed Oct 2020
Boston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
HealthtechMedical Devices
John AbelePeter NicholasLance BatesinJonathan R. Monson(Executive Vice President and Chief Financial Officer)Miriam O'Sullivan(Senior Vice President, Chief Human Resources Officer)inMichael F. Mahoney(Chairman of the Board, President and Chief Executive Officer)
Co-investorsAndera PartnersCatalyst Health VenturesCouncilExcelestar VenturesGood Growth CapitalLongitude Capital+6 more
CalciMedica is a clinical-stage biopharmaceutical company developing CRAC (calcium release-activated calcium) channel inhibition therapies for serious acute and chronic inflammatory, immunologic, and cardiopulmonary diseases.
BiotechHealthtechLa Jolla, US
Kenneth A. Stauderman(Co-founder)inGonul Velicelebi(Co-founder)Daniel Geffken(Executive Officer)A. Rachel Leheny(Executive Officer, Director)Michael J. Dunn(Executive Officer)inStephen Bardin(Chief Financial Officer)in
Co-investorsAisling CapitalClarusClarus LifesciencesOrbiMed
Stereotaxis develops robotic systems for interventional medicine, focused on endovascular and cardiac procedures such as cardiac ablation.
HealthtechMedical DevicesRoboticsSaint Louis, US
David L. Fischel(Executive Officer, Director)inKimberly R. Peery(Executive Officer, Director)Paul A. Brathwaite(Vice President, Research and Development.)inMartin C Stammer(Chief Financial Officer.)David A Giffin(Vice President, Human Resources.)inFrank J. Cheng(Senior Vice President, Marketing and Business Development.)in
Co-investorsSupernova Invest
Artielle Immunotherapeutics develops DRhQ, a therapeutic platform that targets the CD74 receptor and inhibits macrophage migration inhibitory factor (MIF) to treat neuroinflammatory conditions such as progressive multiple sclerosis and advanced cancers.
BiotechDeep TechHealthtechPortland, US
Renee Shirley(Founder)
Co-investorsAvalon BioVenturesLifeX Ventures
BiotechMiramar, US
Hing C Wong(Executive Officer, Director)Peter Rhode(Executive Officer)
BoardAdam Waldman(Director)Fred Middleton(Director)C. Boyder Gray(Director)
Co-investorsOberland Capital
Asteres builds ScriptCenter automated kiosks and lockers that let patients pick up pharmacist-filled prescriptions and healthcare products securely at any hour, while pharmacy staff retain control over filling and checking.
Digital HealthHardwareHealthtechMedical Devices
Linda Pinney(Founder)inDavid J. Lenny(President & CEO)in
Philips provides cardiac monitoring and diagnostic solutions that connect patient monitoring across hospital and home settings.
Digital HealthHealthtechMedical Devices
Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.
BiotechHealthtechMedical DevicesDurham, US
Mike Sherman(Chief Executive Officer and President)W. Garrett Nichols(Chief Medical Officer)Michael A. Alrutz(Executive Officer)Randall Lanier(Chief Science Officer)Roy W. Ware(Chief Manufacturing and Technology Officer)Heather Knight-Trent(Vice President of Regulatory Affairs)
Co-investorsAisling CapitalAlta PartnersAsset Management CompanyCanaan PartnersFrazier Life SciencesPappas Capital
DalCor Pharmaceuticals is a biopharmaceutical company developing dalcetrapib, a pharmacogenetic precision medicine for cardiovascular disease that targets patients with the ADCY9 AA genotype.
BiotechDeep TechDigital Health
Fouzia Laghrissi-Thode(Chief Executive Officer)inMichael Dixon(Chief Financial Officer)inTherese Heinonen(Chief Development Officer)inDiane Sullivan(Chief Commercial Officer)
Dendreon develops and manufactures cellular immunotherapies, including PROVENGE (sipuleucel-T), an FDA-approved cellular immunotherapy for prostate cancer patients.
BiotechHealthtech
William Amickin
Co-investorsRho Capital PartnersRho Ventures
Skyepharma is a contract development and manufacturing organization (CDMO) specializing in classic and complex oral solid dosage forms, offering product development, manufacturing, and packaging services.
Advanced ManufacturingBiotechHealthtechMedical DevicesFrance, FR
Sébastien Mas(CEO)inNicolas Bedel(Chief Business Officer)inLudivine Laugerette(Quality Director & Qualified Person Site)inChahrazed Derbal(Manufacturing Director)inVirginie Mattens(Head of Human Resources)in
DePuy Synthes develops orthopedic medical devices and solutions including joint reconstruction, trauma, extremities, craniomaxillofacial, spinal surgery, and sports medicine products, along with digital surgery technologies.
HealthtechMedical Devices
Digirad designed and manufactured solid-state nuclear medicine imaging cameras and provided turnkey diagnostic imaging services to hospitals and outpatient providers.
Suwanee, US
Matthew G. Molchan(Executive Officer, Director)David Noble(Executive Officer)John W. Sayward(Director)Michael A. Cunnion(Director)Dimitrios J. Angelis(Director)John M. Climaco(Director)
Digirad manufactures portable nuclear medicine imaging cameras for cardiology and general nuclear imaging applications.
HardwareMedical Devices
Dynavax is a commercial-stage biopharmaceutical company that develops and commercializes vaccines against infectious diseases using its adjuvant technology.
BiotechHealthtechDüsseldorf, DE
Ryan Spencer(Chief Executive Officer)inDavid Novack(President and Chief Operating Officer)inRobert Janssen(Chief Medical Officer and Senior Vice President, Clinical Development)inKelly MacDonald(Chief Financial Officer)inJeff Coon(Chief Human Resources Officer)Donn Casale(Chief Commercial Officer)in
Novartis is a pharmaceutical company developing breakthrough medicines across therapeutic areas including oncology and cardiovascular disease.
BiotechMedical Devices
Ethicon develops surgical products and technologies including wound closure, hemostats, surgical stapling, surgical energy, antimicrobial dressings, and surgical instruments, along with clinical education programs for surgeons.
HealthtechMedical Devices
Co-investorsCalifornia Technology Ventures
Glycomine develops therapeutics for rare diseases, many of which currently lack disease-modifying treatment options.
Biotech
Steven Axon(Chief Executive Officer)inHicham Alaoui(Chief Scientific Officer)inRose Marino(Chief Medical Officer)inPeter McWilliams(Chief Business Officer)Geoffrey Hird(Chief Technology Officer)in
Co-investorsAdvent Life SciencesMission Bay CapitalMission BiocapitalRemiges Ventures, Inc.RiverVest Venture PartnersSanofi Ventures
Philips develops health technology and consumer products for patients, healthcare providers, and households, with an emphasis on durable, recyclable products.
Circular EconomyConsumerHealthtechMedical DevicesAmsterdam, NL
Co-investorsExcel Venture ManagementNew Enterprise Associates (NEA)
Bionano Genomics develops optical genome mapping (OGM) systems, software, and sample-preparation tools for detecting structural variants and chromosomal aberrations across cancer, genetic disease, reproductive health, and cell therapy applications.
BiotechHealthtechMedical Devices
Metavention is developing a treatment that targets the sympathetic nervous system to disrupt overactive nerves believed to contribute to high blood pressure and other metabolic diseases.
BiotechHealthtechMedical Devices
Co-investorsVensana Capital
Pacira develops and commercializes non-opioid therapies for postsurgical, chronic, and musculoskeletal pain, and is advancing a gene therapy pipeline candidate.
BiotechHealthtech
Regeneron is a biotechnology company that develops medicines ranging from biologics to genetic medicines to treat serious diseases across areas such as metabolic disease, ophthalmology, and rare disease.
BiotechHealthtechTarrytown, US
Co-investorsRidgeback CapitalvenBio PartnersWireframe Ventures
Sotera Wireless manufactures the ViSi Mobile System, a wearable patient monitoring platform that continuously tracks vital signs including blood pressure, oxygen saturation, heart rate, and ECG in general hospital care settings.
AI & Machine LearningHealthtechMedical Devices
TheraVida is a clinical-stage specialty pharmaceutical company developing combination drug therapies for patients with hyperhidrosis (excessive sweating).
BiotechMedical DevicesChapel Hill, US
Benjamin F. McGraw(CEO & Chairman)Rhonda Donahoe(CFO)Assad Kazeminy(VP, Business Development)
Merck is a pharmaceutical company focused on developing medicines and vaccines for patients globally, guided by a science-led innovation strategy.
BiotechHealthtechMedical DevicesRahway, US
Co-investorsAisling CapitalAtlas VentureHM Venture PartnersSPRINGROCK VENTURESThe Column Group
Transforming the lives of patients through a functional cure for Type 1 Diabetes
BiotechSan Diego, US
Brittany Bradrick(Executive Officer)Anne Sandan(Executive Officer)Elizabeth Bui(Executive Officer)Steve White(Executive Officer)Howard Foyt(Executive Officer)inKevin D'Amour(Executive Officer)in
Co-investorsArtis VenturesBain Capital Life SciencesRA CapitalThe Vertical GroupRed Tree Venture
XOMA Royalty is a biotech royalty aggregator that acquires the economic rights to future milestone and royalty payments tied to partnered pre-commercial clinical candidates, providing sellers with non-dilutive, non-recourse funding.
BiotechFintech
Owen Hughes(Chief Executive Officer)inJeffrey Trigilio(Chief Financial Officer)inBrad Sitko(Chief Investment Officer)inMaricel Montano(Chief Legal Officer)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CalciMedica SubsidiarySotera WirelessAlxnArtielleAsteresAxikin PharmaceuticalsCardioNetCephalon IncCrbardDalco PharmaDendreonDynavaxEndocyteGlycomineIntermuneISTA NASDAQ: ISTA www.istavision.comIsta VisionKadmusLiphorusLiphorus www.liphorus.comMetaventionOntargetjobsPaciraPulsar VascularRegeneronSenhwabiosciencesTaligen TherapeuticsTheravidaTorax MedicalUltraBridgeUniversity of Colorado's License Equity Holdings, Inc. (ULEHI)VentritexVicalVical NASDAQ: VICL www.vical.comXOMA
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 24
4 IPOs · 20 acquisitions · showing 22HCW BiologicsNASDAQ: HCWBBoston ScientificNYSE: BSXCalciMedica NASDAQ: CALC www.calcimedica.comNASDAQ: CALCStereotaxis NASDAQ: STXS www.stereotaxis.comNYSE: STXSSotera Wirelessacq. by Foxconn (Hon Hai Precision Industry)Actimisacq. by Boehringer IngelheimAderisacq. by Schwarz PharmaDendreonacq. by Valeant Pharmaceuticals (later resold to Sanpower Group, then Nanjing Cenbest)DepoTechacq. by SkyePharmaDigiradacq. by TTG Imaging Solutions, LLCDynavaxacq. by SanofiEndocyteacq. by NovartisEndocyte NASDAQ: ECYT www.endocyte.comacq. by NovartisInfraReDxacq. by Nipro CorporationIntermuneacq. by RocheKadmusacq. by N.V. Organon (Akzo Nobel)Naviscanacq. by CMR NaviscanSjmacq. by AbbottTorax Medicalacq. by Ethicon (Johnson & Johnson)Ventritexacq. by St. Jude MedicalVicalacq. by Brickell Biotech (later renamed Fresh Tracks Therapeutics)XOMAacq. by Ligand Pharmaceuticals
Portfolio news
latest coverage across their companies
HCW Biologics · stocktitan.net · Aug 20, 2026
Glycomine · finsmes.com · Apr 16, 2025
Frequently asked questions
- How many investments has Sanderling Ventures made?
- Sanderling Ventures has 72 tracked investments, 24 of which have exited.
- What stage does Sanderling Ventures invest at?
- Sanderling Ventures invests at the Seed, Series A, Late Stage stages.
- What is Sanderling Ventures's typical check size?
- Sanderling Ventures typically writes checks of $50K – $1M.
- What sectors does Sanderling Ventures focus on?
- Sanderling Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Sanderling Ventures located?
- Sanderling Ventures is headquartered in San Mateo, US.
- Who does Sanderling Ventures co-invest with?
- Sanderling Ventures most often shares deals with Aisling Capital, New Enterprise Associates (NEA), Oak Investment Partners, among 45 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
T. Rowe Price is a global asset management firm that actively invests across markets to pursue opportunities on behalf of its clients.
New Leaf Venture Partners is a venture capital firm investing in innovative healthcare companies.